KUALA LUMPUR: Malaysia is expected to receive its first shipment of the COVID-19 oral antiviral treatment, Paxlovid by Pfizer, in two weeks, said Health Minister Khairy Jamaluddin.
He said for the first phase of the procurement, Malaysia had purchased 110,000 patient-courses (for 110,000 patients) to be given to high-risk individuals.
"If we find the use of the drug as effective as (stated in) the information we have received, we will increase the purchase of the drug, Paxlovid from Pfizer.
"There are two more (drugs) that we will buy (namely) Molnupiravir, and another is from AstraZeneca, but it has not been finalised," he told reporters after launching the National Kidney Foundation (NKF) 16th Annual Dialysis Conference here today.
Meanwhile, in his speech earlier, Khairy suggested a new feature in the MySejahtera application which allows the public to pledge to become organ donors.
He said the move was necessary with the increase in chronic kidney disease patients in the country, while the number of individuals who pledged to be organ donors was declining.
In fact, Malaysia is among the countries with the lowest organ donors, he added.
"I am going to do my best to push for pledges and make it easier for people to pledge their organs ... I'm trying to get the MySejahtera to be added with a button so you can just press the button and pledge to be donor organs,"he said.
According to Khairy, more than 40,000 chronic kidney patients relied on dialysis treatment in 2016 and based on projections, if the trend is not reduced, the number of patients is expected to increase to 100,000 people.
He said measures for the prevention and detection of chronic diseases through health screening should also be promoted, whereby the government had implemented the Health Care Scheme for the B40 (PeKa B40) to help the group undergo health screening for free.
However, he said, of the 5 million individuals who were eligible to undergo health screening under PeKa B40, less than 12 per cent of them went for the health screening.
-- BERNAMA
Bernama
Sat Mar 05 2022
![Malaysia to receive Pfizer's Paxlovid for COVID-19 treatment in two weeks - Khairy Malaysia to receive Pfizer's Paxlovid for COVID-19 treatment in two weeks - Khairy](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2022-03/71646285055_KhairyJamaluddin.jpg)
Khairy said for the first phase of the procurement, Malaysia had purchased 110,000 patient-courses (for 110,000 patients) to be given to high-risk individuals. - Astro AWANI/Shahir Omar
#AWANIRingkas 15 Ogos 2024 | 9 AM
Berikut merupakan rangkuman berita setakat 9 pagi, 15 Ogos 2024
1️⃣ TPM wakili Malaysia di EMM di Peru
2️⃣ Misteri kehilangan Nidza Afham
3️⃣ Rundingan gencatan Gaza di Qatar hari ini
#awaniringkas
1️⃣ TPM wakili Malaysia di EMM di Peru
2️⃣ Misteri kehilangan Nidza Afham
3️⃣ Rundingan gencatan Gaza di Qatar hari ini
#awaniringkas
Belia & pekerjaan: Pengangguran belia global menurun, cabaran tetap ada
Walaupun kadar pengangguran belia global menurun, kebimbangan meningkat mengenai belia NEET (tidak bekerja, belajar, atau menjalani latihan). Laporan Pertubuhan Buruh Antarabangsa (ILO) mendedahkan jurang dan cabaran besar yang terus menghantui belia, terutama di wilayah tertentu dan kalangan wanita muda. Bagaimana untuk menganalisis tren global dalam konteks keadaan tempatan bagi memastikan penemuan antarabangsa dapat disesuaikan dengan strategi nasional?
AWANI Pagi I UiTM 25 Tahun, Apa Seterusnya?
Dalam meraikan pencapaian UiTM yang telah mencapai usia 25 tahun, ia kekal sebagai universiti teramai melahirkan graduan yang menyumbang tenaga, dan kemahiran merentas industri di Malaysia.
Ikuti AWANI Pagi untuk kita ikuti bagaimana UiTM mahu kekal melahirkan graduan graduan relevan dalam pasaran dunia yang semakin berubah.
Ikuti AWANI Pagi untuk kita ikuti bagaimana UiTM mahu kekal melahirkan graduan graduan relevan dalam pasaran dunia yang semakin berubah.
![SUHAKAM gesa penggantungan semua operasi pengusiran Bajau Laut SUHAKAM gesa penggantungan semua operasi pengusiran Bajau Laut](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2022-12/51670516991_suhakam.jpg)
SUHAKAM gesa penggantungan semua operasi pengusiran Bajau Laut
SUHAKAM gesa penggantungan segera semua operasi dan aktiviti pengusiran yang sedang berlaku di Semporna.
Data & Statistik: Kadar pengangguran global belia 2024
Walaupun kadar pengangguran belia global menurun, jumlah belia yang tidak bekerja, belajar, atau menjalani latihan golongan NEET masih membimbangkan. Laporan terkini Pertubuhan Buruh Antarabangsa (ILO) menunjukkan cabaran serius untuk belia, terutamanya di kawasan tertentu dan dalam kalangan wanita muda.
![Pencipta biskut Famous Amos meninggal dunia pada usia 88 tahun Pencipta biskut Famous Amos meninggal dunia pada usia 88 tahun](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-08/51723685297_WallyAmosJrFamou.jpg)
Pencipta biskut Famous Amos meninggal dunia pada usia 88 tahun
"Famous Amos adalah kisah kejayaan besar Amerika dan sumber kebanggaan bagi masyarakat kulit hitam."
![Lebih 1,600 premis PKS sertai program SOLVE 4 SME Lebih 1,600 premis PKS sertai program SOLVE 4 SME](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-08/71723651455_TBSOLVE.jpg)
Lebih 1,600 premis PKS sertai program "SOLVE 4 SME"
JKKP memaklumkan penyertaan itu melebihi sasaran jabatan itu dan telah memberi manfaat kepada 70,824 pekerja PKS.
![PRK Nenggiri: PN ada peluang menang, tapi jangan over-confident - Muhyiddin PRK Nenggiri: PN ada peluang menang, tapi jangan over-confident - Muhyiddin](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-04/51713678198_MuhyiddinYassin.jpg)
PRK Nenggiri: "PN ada peluang menang, tapi jangan over-confident" - Muhyiddin
Muhyiddin optimis dengan kemenangan calon PN, Mohd Rizwadi Ismail sekali gus mempertahankan kerusi DUN Nenggiri.
![Ahli ekonomi yakin pertumbuhan KDNK sekitar 5.8 peratus pada suku kedua 2024 Ahli ekonomi yakin pertumbuhan KDNK sekitar 5.8 peratus pada suku kedua 2024](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-06/81717305735_EkonomiMalaysia.jpg)
Ahli ekonomi yakin pertumbuhan KDNK sekitar 5.8 peratus pada suku kedua 2024
Kalangan ahli ekonomi yakin KDNK Malaysia bagi suku kedua 2024 akan berkembang pada 5.8 peratus berbanding 4.2 peratus pada suku pertama tahun ini.
AWANI Pagi: Berita tumpuan & menarik di astroawani.com [15 Ogos 2024]
Antara fokus AWANI Pagi bersama Nursyazwani Saiful Sham dan Afiezy Azaman
- Mayat lelaki di jambatan Klang dipercayai YouTuber Nidza Afham
- BNM denda Maybank, CIMB kerana gangguan perkhidmatan berpanjangan
- JIWA SME: Inovasi kuih sejuk beku jadi kudapan jemaah tunai umrah
#AWANInews #AWANIpagi
- Mayat lelaki di jambatan Klang dipercayai YouTuber Nidza Afham
- BNM denda Maybank, CIMB kerana gangguan perkhidmatan berpanjangan
- JIWA SME: Inovasi kuih sejuk beku jadi kudapan jemaah tunai umrah
#AWANInews #AWANIpagi
![Ubat Paxlovid masih berkesan rawat COVID-19 Ubat Paxlovid masih berkesan rawat COVID-19](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2023-10/61696481353_MuhammadRadzi.jpg)
Ubat Paxlovid masih berkesan rawat COVID-19
Rawatan antiviral itu boleh mengurangkan gejala COVID-19 dan mengelakkan penyakit daripada menjadi lebih teruk.
![Vaksinasi, ubat antiviral strategi tangani gelombang baharu COVID-19 - Khairy Vaksinasi, ubat antiviral strategi tangani gelombang baharu COVID-19 - Khairy](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2022-06/41654690954_KhairyJamaludin.jpg)
Vaksinasi, ubat antiviral strategi tangani gelombang baharu COVID-19 - Khairy
Masih terdapat lebih 30 peratus golongan dewasa di negara ini yang belum mendapatkan dos penggalak setakat 7 Julai.
![Pfizer dakwa pil COVID-19 keluarannya mampu kurangkan kemasukan ke hospital Pfizer dakwa pil COVID-19 keluarannya mampu kurangkan kemasukan ke hospital](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-11/51636156278_Paxlovid.jpg)
Pfizer dakwa pil COVID-19 keluarannya mampu kurangkan kemasukan ke hospital
Pfizer menamatkan ujian klinikal ke atas Paxlovid, susulan keputusan awal yang sangat positif.